Kohjin Bio Co., Ltd. (TYO:177A)
1,202.00
-18.00 (-1.48%)
At close: Feb 6, 2026
Kohjin Bio Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 2,587 | 3,149 | 1,726 | 1,462 | 1,734 | 1,176 |
Cash & Short-Term Investments | 2,587 | 3,149 | 1,726 | 1,462 | 1,734 | 1,176 |
Cash Growth | 49.88% | 82.45% | 18.06% | -15.69% | 47.48% | 60.83% |
Accounts Receivable | 999 | 985 | 917 | 837 | 1,134 | 552.21 |
Other Receivables | - | 13 | 9 | 8 | 17 | - |
Receivables | 999 | 998 | 926 | 845 | 1,151 | 552.21 |
Inventory | 877 | 880 | 683 | 1,101 | 519 | 438.33 |
Other Current Assets | 175 | 39 | 74 | 70 | 29 | 306.47 |
Total Current Assets | 4,638 | 5,066 | 3,409 | 3,478 | 3,433 | 2,473 |
Property, Plant & Equipment | 3,462 | 3,253 | 2,586 | 2,171 | 1,709 | 1,582 |
Long-Term Investments | 721 | 656 | 553 | 468 | 443 | - |
Other Intangible Assets | 21 | 27 | 2 | 4 | 5 | 6.59 |
Long-Term Deferred Tax Assets | - | 62 | 36 | 11 | 2 | - |
Other Long-Term Assets | 1 | 2 | 3 | 2 | 3 | 766.22 |
Total Assets | 8,843 | 9,066 | 6,589 | 6,134 | 5,595 | 4,828 |
Accounts Payable | 214 | 209 | 246 | 236 | 396 | 346.51 |
Accrued Expenses | 69 | 79 | 63 | 76 | 60 | - |
Short-Term Debt | 1,500 | 1,500 | 1,500 | 1,200 | 900 | 796.6 |
Current Portion of Long-Term Debt | 150 | 150 | 150 | 864 | 209 | - |
Current Portion of Leases | - | 51 | 52 | 20 | 20 | - |
Current Income Taxes Payable | 75 | 114 | 56 | 261 | 244 | - |
Other Current Liabilities | 327 | 384 | 331 | 364 | 369 | 406.91 |
Total Current Liabilities | 2,335 | 2,487 | 2,398 | 3,021 | 2,198 | 1,550 |
Long-Term Debt | 300 | 375 | 525 | - | 1,064 | 1,739 |
Long-Term Leases | - | 310 | 242 | 14 | 34 | - |
Pension & Post-Retirement Benefits | 48 | 46 | 42 | 42 | 34 | - |
Long-Term Deferred Tax Liabilities | - | - | - | - | 9 | - |
Other Long-Term Liabilities | 348 | 67 | 40 | 40 | 40 | 107.47 |
Total Liabilities | 3,031 | 3,285 | 3,247 | 3,117 | 3,379 | 3,397 |
Common Stock | 1,253 | 1,253 | 426 | 426 | 426 | 1,431 |
Additional Paid-In Capital | 1,153 | 1,153 | 325 | 325 | 325 | - |
Retained Earnings | 3,344 | 3,265 | 2,528 | 2,222 | 1,434 | - |
Comprehensive Income & Other | 62 | 110 | 63 | 44 | 31 | - |
Shareholders' Equity | 5,812 | 5,781 | 3,342 | 3,017 | 2,216 | 1,431 |
Total Liabilities & Equity | 8,843 | 9,066 | 6,589 | 6,134 | 5,595 | 4,828 |
Total Debt | 1,950 | 2,386 | 2,469 | 2,098 | 2,227 | 2,536 |
Net Cash (Debt) | 637 | 763 | -743 | -636 | -493 | -1,360 |
Net Cash Per Share | 124.62 | 151.27 | -178.39 | -152.70 | -145.55 | - |
Filing Date Shares Outstanding | 5.11 | 5.11 | 5.11 | 4.17 | 3.39 | - |
Total Common Shares Outstanding | 5.11 | 5.11 | 4.17 | 4.17 | 3.39 | - |
Working Capital | 2,303 | 2,579 | 1,011 | 457 | 1,235 | - |
Book Value Per Share | 1137.02 | 1130.96 | 802.40 | 724.37 | 654.24 | - |
Tangible Book Value | 5,791 | 5,754 | 3,340 | 3,013 | 2,211 | - |
Tangible Book Value Per Share | 1132.91 | 1125.67 | 801.92 | 723.41 | 652.77 | - |
Order Backlog | - | 72.39 | 31.05 | 20.61 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.